Ketamine Clinic in Japan for Inbound Medical Treatment: Nagoya Anesthesia Clinic
Ketamine, a widely used general anesthetic with a history dating back over 50 years, has also been employed in the United States for the treatment of mental disorders and chronic pain for the past decade. Unlike conventional medications, which may take time to alleviate symptoms, Ketamine offers rapid relief within hours to up to three weeks of administration. Moreover, it is associated with minimal long-term side effects, making it a promising treatment option.
Drawing on their extensive experience of performing Ketamine infusions for various pain and mental disorders, Nagoya Anesthesia Clinic has established the Ketamine Clinic based on Ketamine's potent analgesic and antidepressant properties. Typically, ketamine infusions are administered in sets of 3 to 6 sessions over a span of 1 to 3 weeks, followed by a maintenance therapy once a month, known for its low incidence of long-term side effects.
Nagoya Anesthesia Clinic is dedicated to provision of exceptional care and innovative treatments to patients in Japan and beyond, welcoming patients for inbound medical treatment of treatment-resistant depression, OCD, PTSD, and intractable chronic pain starting from October 2023. Building on their extensive ketamine infusion experience, the clinic aims to support individuals coping with treatment-resistant conditions through innovative, evidence-based, and compassionate approaches.
· Nagoya Anesthesia Clinic “Ketamine Clinic” Information Page:
https://nagoyamasui.com/ketamine3
· “Stiff Neck Botox” Information Page:
https://nagoyamasui.com/botox3
· “Tennis Elbow PRP Therapy” Information Page:
https://nagoyamasui.com/prp3
View source version on businesswire.com: https://www.businesswire.com/news/home/20231113434750/en/
Website: https://nagoyamasui.com/ketamine3
Contact
Nagoya Anesthesia Clinic
JTB Medical & Healthcare
jmhc_info@j-medical-healthcare.com
This news is a press release provided by Nagoya Anesthesia Clinic.
